These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7906496)

  • 1. Mechanisms of action of mycophenolic acid.
    Allison AC; Kowalski WJ; Muller CD; Eugui EM
    Ann N Y Acad Sci; 1993 Nov; 696():63-87. PubMed ID: 7906496
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppressive activity of mycophenolate mofetil.
    Eugui EM; Allison AC
    Ann N Y Acad Sci; 1993 Jun; 685():309-29. PubMed ID: 8363235
    [No Abstract]   [Full Text] [Related]  

  • 3. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
    Allison AC; Eugui EM
    Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil.
    Allison AC; Eugui EM
    Immunol Rev; 1993 Dec; 136():5-28. PubMed ID: 7907572
    [No Abstract]   [Full Text] [Related]  

  • 5. The design and development of an immunosuppressive drug, mycophenolate mofetil.
    Allison AC; Eugui EM
    Springer Semin Immunopathol; 1993; 14(4):353-80. PubMed ID: 8322167
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
    Sokoloski JA; Sartorelli AC
    Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
    Sokoloski JA; Blair OC; Sartorelli AC
    Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation and reduction of intracellular GTP levels in HL-60 and U937 cells upon treatment with IMP dehydrogenase inhibitors.
    Inai K; Tsutani H; Yamauchi T; Nakamura T; Ueda T
    Adv Exp Med Biol; 1998; 431():549-53. PubMed ID: 9598126
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth inhibition and induction of phenotypic alterations in MCF-7 breast cancer cells by an IMP dehydrogenase inhibitor.
    Sidi Y; Panet C; Wasserman L; Cyjon A; Novogrodsky A; Nordenberg J
    Br J Cancer; 1988 Jul; 58(1):61-3. PubMed ID: 2901850
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new immunosuppressor: CellCept].
    Mouly-Bandini A
    Presse Med; 2001 Jan; 30(2):66-7. PubMed ID: 11244816
    [No Abstract]   [Full Text] [Related]  

  • 11. [Review of a new immunosuppressive drug: enteric-coated mycophenolate sodium (Myfortic)].
    Sánchez-Fructuoso AI
    Nefrologia; 2005; 25(3):234-42, 244. PubMed ID: 16053004
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitors of IMP dehydrogenase prevent sindbis virus replication and reduce GTP levels in Aedes albopictus cells.
    Malinoski F; Stollar V
    Virology; 1981 Apr; 110(2):281-9. PubMed ID: 6111860
    [No Abstract]   [Full Text] [Related]  

  • 13. Increases in purine excretion and rate of synthesis by drugs inhibiting IMP dehydrogenase or adenylosuccinate synthetase activities.
    Willis RC; Seegmiller JE
    Adv Exp Med Biol; 1979; 122B():237-41. PubMed ID: 44644
    [No Abstract]   [Full Text] [Related]  

  • 14. Enteric-coated mycophenolate sodium: an update.
    Zhang W; Ding C; Zheng S
    Int J Clin Pract Suppl; 2014 Apr; (181):1-3. PubMed ID: 24673712
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacodynamic monitoring of immunosuppressive drugs.
    Yatscoff RW; Langman LJ; LeGatt DF
    Transplant Proc; 1996 Dec; 28(6):3013-5. PubMed ID: 8962169
    [No Abstract]   [Full Text] [Related]  

  • 16. The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signal.
    Chaigne-Delalande B; Guidicelli G; Couzi L; Merville P; Mahfouf W; Bouchet S; Molimard M; Pinson B; Moreau JF; Legembre P
    J Immunol; 2008 Dec; 181(11):7630-8. PubMed ID: 19017951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil as induction therapy after liver transplantation.
    McDiarmid SV
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S85-9. PubMed ID: 10431021
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological effects of inhibition of guanine nucleotide synthesis by mycophenolic acid in cultured neuroblastoma cells.
    Cass CE; Lowe JK; Manchak JM; Henderson JF
    Cancer Res; 1977 Sep; 37(9):3314-20. PubMed ID: 195725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of inhibition of guanine nucleotide synthesis by mycophenolic acid and virazole.
    Lowe JK; Brox L; Henderson JF
    Cancer Res; 1977 Mar; 37(3):736-43. PubMed ID: 837373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
    Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.